SeaSpine Holdings Corporation (SPNE): Price and Financial Metrics
GET POWR RATINGS... FREE!
SPNE POWR Grades
- Growth is the dimension where SPNE ranks best; there it ranks ahead of 87.2% of US stocks.
- The strongest trend for SPNE is in Stability, which has been heading up over the past 31 weeks.
- SPNE ranks lowest in Momentum; there it ranks in the 15th percentile.
SPNE Stock Summary
- The ratio of debt to operating expenses for SeaSpine Holdings Corp is higher than it is for about just 20.65% of US stocks.
- SPNE's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 16.36% of US stocks.
- With a year-over-year growth in debt of 244.79%, SeaSpine Holdings Corp's debt growth rate surpasses 95.71% of about US stocks.
- Stocks that are quantitatively similar to SPNE, based on their financial statements, market capitalization, and price volatility, are CLXT, XENE, ISR, MPX, and UAMY.
- SPNE's SEC filings can be seen here. And to visit SeaSpine Holdings Corp's official web site, go to www.seaspine.com.
SPNE Price Target
For more insight on analysts targets of SPNE, see our SPNE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $28.03 | Average Broker Recommendation | 1.25 (Strong Buy) |
SPNE Stock Price Chart Interactive Chart >
SPNE Price/Volume Stats
| Current price | $20.10 | 52-week high | $22.97 |
| Prev. close | $19.65 | 52-week low | $8.78 |
| Day low | $19.35 | Volume | 303,400 |
| Day high | $20.50 | Avg. volume | 127,865 |
| 50-day MA | $20.56 | Dividend yield | N/A |
| 200-day MA | $17.17 | Market Cap | 666.54M |
SeaSpine Holdings Corporation (SPNE) Company Bio
SeaSpine Holdings Corporation is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company was founded in 2015 and is based in in Vista, California
Latest SPNE News From Around the Web
Below are the latest news stories about SeaSpine Holdings Corp that investors may wish to consider to help them evaluate SPNE as an investment opportunity.
SeaSpine Announces Limited Commercial Launch of the WaveForm® L (Lateral) 3D-Printed Interbody SystemCARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm L (Lateral) Interbody System. WaveForm L is designed for the LLIF (lateral lumbar interbody fusion) procedure, and seamlessly integrates with the entire Regatta NanoMetalene® lateral interbody portfolio, including the recent |
SeaSpine Reports Granting of Inducement AwardsCARLSBAD, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has issued inducement awards to Beau Standish and 44 non-executive employees in connection with the closing of its acquisition of 7D Surgical. The awards were made on June 2, 2021 under SeaSpine’s 2020 Employment Inducement Equity Incentive Award Plan, which provides for t |
SeaSpine Holdings (SPNE) Investor Presentation - SlideshowThe following slide deck was published by SeaSpine Holdings Corporation in conjunction with this event.... |
SeaSpine Closes Acquisition Of 7D Surgical; Street Says BuyMedical technology company SeaSpine Holdings (SPNE) has completed the $110 million acquisition of 7D Surgical. SeaSpine provides surgical technology and solutions for treating spinal disorders. 7D surgical develops optical technologies and machine vision-based algorithms in order to improve surgical workflow and patient care. The acquisition is expected to accelerate SeaSpine’s short-term revenue growth and help SeaSpine address the complete process of patient care while also expanding the scope of its services beyond the operating room. SeaSpine President and CEO Keith C. Valentine said, “We are truly excited to welcome the 7D Surgical team and their market-leading Flash Navigation technology to the SeaSpine family.” Valentine added, “The acquisition of 7D Surgical brings an additive c... |
SeaSpine closes 7D Surgical acquisitionSeaSpine Holdings (SPNE) announces the closing of the previously announced acquisition of 7D Surgical, in a cash and stock deal valued at $110M.7D Surgical is a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care.7D Surgical shareholders will receive an ~4.29M shares of... |
SPNE Price Returns
| 1-mo | 2.19% |
| 3-mo | 5.13% |
| 6-mo | 17.34% |
| 1-year | 76.01% |
| 3-year | 43.06% |
| 5-year | 109.38% |
| YTD | 15.19% |
| 2020 | 45.30% |
| 2019 | -34.16% |
| 2018 | 80.24% |
| 2017 | 28.10% |
| 2016 | -54.02% |
Continue Researching SPNE
Here are a few links from around the web to help you further your research on SeaSpine Holdings Corp's stock as an investment opportunity:SeaSpine Holdings Corp (SPNE) Stock Price | Nasdaq
SeaSpine Holdings Corp (SPNE) Stock Quote, History and News - Yahoo Finance
SeaSpine Holdings Corp (SPNE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...